These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 32996)

  • 1. Phospholipid analysis of the chick ventricles in the early stages of development when their excitability changes in tetrodotoxin or in sodium substitute media.
    Ishima Y; Waku K
    Comp Biochem Physiol C Comp Pharmacol; 1978; 61 C(2):283-6. PubMed ID: 32996
    [No Abstract]   [Full Text] [Related]  

  • 2. [Demonstration, by the use of inhibitors, of an evolution of cardiac membrane permeabilities at the early stages of development in the chick embryo].
    Renaud D; Le Douarin G
    C R Acad Hebd Seances Acad Sci D; 1972 Jan; 274(3):418-21. PubMed ID: 4621923
    [No Abstract]   [Full Text] [Related]  

  • 3. Tetrodotoxin sensitivity in the developing and adult chick heart.
    Marcus NC; Fozzard H
    J Mol Cell Cardiol; 1981 Mar; 13(3):335-40. PubMed ID: 6267302
    [No Abstract]   [Full Text] [Related]  

  • 4. Development of sensitivity to tetrodotoxin of chick embryonic hearts with age.
    Shigenobu K; Sperelakis N
    J Mol Cell Cardiol; 1971 Dec; 3(3):271-86. PubMed ID: 5293984
    [No Abstract]   [Full Text] [Related]  

  • 5. Retention of fully differentiated electrophysiological properties of chick embryonic heart cells in culture.
    McLean MJ; Sperelakis N
    Dev Biol; 1976 May; 50(1):134-41. PubMed ID: 1269825
    [No Abstract]   [Full Text] [Related]  

  • 6. Physiology of membrane lipid asymmetry.
    Bevers EM; Smeets EF; Comfurius P; Zwaal RF
    Lupus; 1994 Aug; 3(4):235-40. PubMed ID: 7804308
    [No Abstract]   [Full Text] [Related]  

  • 7. Action potentials in chick atria. Ontogenetic changes in the dependence of tetrodotoxin-resistant action potentials on calcium, strontium, barium.
    Pappano AJ
    Circ Res; 1976 Jul; 39(1):99-105. PubMed ID: 1277409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clotting activity of platelet phospholipids in rat and man.
    Gautheron P; Dumont E; Renaud S
    Thromb Diath Haemorrh; 1974 Dec; 32(2-3):382-90. PubMed ID: 4450192
    [No Abstract]   [Full Text] [Related]  

  • 9. Phospholipids as a possible instrument for translocation of nascent proteins across biological membranes.
    Rietveld A; de Kruijff B
    Biosci Rep; 1986 Sep; 6(9):775-82. PubMed ID: 3028524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electrophysiological properties of chick embryonic hearts grafted and organ cultured in vitro.
    Renaud JF; Sperelakis N
    J Mol Cell Cardiol; 1976 Nov; 8(11):889-900. PubMed ID: 794492
    [No Abstract]   [Full Text] [Related]  

  • 11. Differentiation-related differences in the plasma membrane phospholipid asymmetry of myogenic and fibrogenic cells.
    Sessions A; Horwitz AF
    Biochim Biophys Acta; 1983 Feb; 728(1):103-11. PubMed ID: 6830770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phospholipid-protein interactions of the plasma-membrane Ca2+-transporting ATPase. Evidence for a tissue-dependent functional difference.
    Missiaen L; Raeymaekers L; Wuytack F; Vrolix M; de Smedt H; Casteels R
    Biochem J; 1989 Nov; 263(3):687-94. PubMed ID: 2532005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Propranolol, chlorpromazine and platelet membrane: a fluorescence study of the drug-membrane interaction.
    Dachary-Prigent J; Dufourcq J; Lussan C; Boisseau M
    Thromb Res; 1979 Jan; 14(1):15-22. PubMed ID: 570739
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of membrane phospholipid compositional changes on adenylate cyclase in LM cells.
    Engelhard VH; Glaser M; Storm DR
    Biochemistry; 1978 Aug; 17(16):3191-200. PubMed ID: 687576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phospholipid composition modulates the Na+-Ca2+ exchange activity of cardiac sarcolemma in reconstituted vesicles.
    Vemuri R; Philipson KD
    Biochim Biophys Acta; 1988 Jan; 937(2):258-68. PubMed ID: 3276350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physiology and pharmacology of developing heart cells.
    Sperelakis N; Pappano AJ
    Pharmacol Ther; 1983; 22(1):1-39. PubMed ID: 6318234
    [No Abstract]   [Full Text] [Related]  

  • 17. Membrane phospholipids are the major determinant of the binding site for factor X activating--and prothrombinase complexes at the surface of human platelets.
    Bevers EM; Rosing J; Zwaal RF
    Agents Actions Suppl; 1986; 20():69-75. PubMed ID: 3468783
    [No Abstract]   [Full Text] [Related]  

  • 18. Altered phospholipid composition affects endocytosis in cultured LM fibroblasts.
    Schroeder F
    Biochim Biophys Acta; 1981 Dec; 649(2):162-74. PubMed ID: 7317390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Action potentials in chick atria. Increased susceptibility to blockade by tetrodotoxin during embryonic development.
    Pappano AJ
    Circ Res; 1972 Sep; 31(3):379-88. PubMed ID: 5057018
    [No Abstract]   [Full Text] [Related]  

  • 20. Cyclic AMP levels in relation to membrane phospholipid variations in Neurospora crassa.
    Gabrielides C; Zrike J; Scott WA
    Arch Microbiol; 1983 Feb; 134(2):108-13. PubMed ID: 6307199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.